Caspases, apoptosis, and Alzheimer disease: Causation, correlation, and confusion

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 9, 2001, Pages 829-838

  Roth, Kevin A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Bcl 2; Cathepsin D; Neurodegenerative disease; Programmed cell death

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE; CATHEPSIN; PROTEIN BCL 2;

ALZHEIMER DISEASE; APOPTOSIS; AUTOPHAGY; CELL LOSS; CELL SURVIVAL; DEGENERATIVE DISEASE; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034830488     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.9.829     Document Type: Review

References (84)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Genetic control of programmed cell death in the nematode Caenorhabditis elegans
3. BCL-2 gene family and the regulation of programmed cell death
4. Caspase structure, proteolytic substrates, and function during apoptotic cell death
5. Caspase-3 is required for apoptosis-associated DNA fragmentation but not for cell death in neurons deprived of potassium
6. Mechanism of programmed cell death in the developing brain
7. From bench to clinic with apoptosis-based therapeutic agents
8. Caspases and neurodegeneration: On the cutting edge of new therapeutic approaches
9. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation
10. Clinicopathology studies in cognitively health aging and Alzheimer disease. Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E. genotype
11. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
12. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
13. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
14. Cell death or synaptic loss in Alzheimer disease
15. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type
16. Quantitative decrease in synaptophysin message expression and increase in Cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles
17. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
18. Translating cell biology into therapeutic advances in Alzheimer's disease
19. Caspase requirement for neuronal apoptosis and neurodegeneration
20. Apoptosis and Alzheimer's disease
21. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease
22. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
23. Immunohistochemical evidence for apoptosis in Alzheimer's disease
24. Evidence for apoptotic cell death in Alzheimer's disease
25. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks
26. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
27. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
28. Mechanisms of cell death in neurodegenerative disorders
29. Apoptosis in neurodegenerative disorders
30. An alternative, nonapoptotic form of programmed cell death
31. Developmental cell death: Morphological diversity and multiple mechanisms
32. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
33. Up-regulation of the lysosomal system in experimental models of neuronal injury: Implications for Alzheimer's disease
34. Aβ may be a planet, but APP is central
35. Molecular cloning of a novel apoptosis-related gene, human Nap1 (NCKAP1), and its possible relation to Alzheimer disease
36. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-l, and CPP32, in Alzheimer's disease
37. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
38. Copernicus revisited: Amyloid beta in Alzheimer's disease
39. Amyloid beta-induced death is Bax-dependent but caspase-independent
40. Sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA-1
41. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
42. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis
43. Presenilin-1 P264L knockin mutation: Differential effects on A beta production, amyloid deposition, and neuronal vulnerability
44. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
45. Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss
46. Vulnerability of synaptosomes from ApoE knock-out mice to structural and oxidative modifications induced by Aβ (1-40): Implications for Alzheimer's disease
47. Apoliproprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
48. Cell death inhibition: Keeping caspases in check
49. ICE, neuronal apoptosis and neurodegeneration
50. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
51. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
52. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex
53. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
54. Caspase-2 mediates neuronal cell death induced by β-amyloid
55. Defects in regulation of apoptosis in caspase-2-deficient mice
56. Changes in caspase expression in Alzheimer's disease: Comparison with development and aging
57. Neuronal apoptosis induced by β-amyloid is mediated by caspase-8
58. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
59. Alternative, non-secretase processing of Alzheimer's β-amyloid precursor protein during apoptosis by caspase-6 and -8
60. A second cytotoxic proteolyric peptide derived from amyloid β-protein precursor
61. Alteration of caspases- and apoptosis-related proteins in brains of patients with Alzheimer's disease
62. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8
63. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
64. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis
65. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
66. Caspase-6 role in apoptosis of human neurons, amyloidogenesis and Alzheimer's disease
67. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons
68. Abortive apoptosis in Alzheimer's disease
69. In situ immunodetection of neuronal Caspase-3 activation in Alzheimer's disease
70. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
71. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death
72. Activated caspase-3 expression in Alzheimer's and aged control brain: Correlation with Alzheimer pathology
73. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease
74. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease
75. Calpain and caspase: Can you tell the difference?
76. Caspases land on APP: One small step for apoptosis, one giant leap for amyloidosis?
77. Evidence for synaptic apoptosis
78. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
79. β-amyloid induces local neurite degeneration in cultured hippocampal neurons: Evidence for neuritic apoptosis
80. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases
81. Par-4 - An emerging pivotal player in neuronal apoptosis and neurodegenerative disorders
82. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease
83. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
84. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy